Inspiremd Inc (NSPR) - News Archive

As InspireMD, Inc. (Nasdaq: NSPR) maneuvers through a dynamic healthcare landscape, the developer of the CGuard Prime carotid stent system continues to make news with strategic decisions and partnerships that could shap...

In an exciting development for the medical technology landscape, InspireMD, Inc. (NASDAQ: NSPR), a trailblazer in carotid stenting solutions, has announced a strategic partnership with NAMSA, a renowned global MedTech C...

In a strategic maneuver to bolster its talent pool, InspireMD, Inc. (Nasdaq: NSPR), a pioneering medical device company focused on stroke prevention, has announced inducement grants under the Nasdaq Listing Rule 5635(c)...

InspireMD Broadens Talent Pool with Strategic Inducement Grants Amid Growth in Carotid Stent DevelopmentIn a notable move highlighting its commitment to securing top talent as it continues to innovate within the medical...

InspireMD s Strategic Inducement Grants: A Step Towards Growth and StabilityIn a recent announcement that highlights its ongoing commitment to attracting top talent, InspireMD, Inc. (Nasdaq: NSPR) has provided details o...

In recent developments concerning the prevention of stroke, InspireMD, Inc. has announced the approval of their Investigational Device Exemption (IDE) application by the U.S. Food and Drug Administration (FDA) for their...

InspireMD Moves Forward with FDA Premarket Approval Application for CGuard Prime Carotid Stent: A Leap in Vascular Technology In a significant advancement for vascular intervention, InspireMD has officially submitted a...

In a milestone achievement for cardiovascular intervention, InspireMD has announced the successful completion of trial enrollment for the CREST-2 study, a pivotal clinical trial that evaluates the effectiveness and safe...

In a significant boost to their efforts, medical device company InspireMD has successfully raised $17.9 million in gross proceeds after the full exercise of its Series H warrant tranche. This milestone achievement came...

InspireMD, a renowned medical device company specializing in innovative stents and embolic protection devices, recently presented the remarkable findings of its C-GUARDIANS U.S. Investigational Device Exemption (IDE) Cl...

A recent announcement by InspireMD, Inc. has unveiled the acceptance of an abstract for presentation at the Leipzig Interventional Course (LINC) 2024. The abstract highlights the one-year outcomes of the C-GUARDIANS Inv...

Carotid artery disease poses a significant threat to the cardiovascular health of individuals worldwide. With the aim of preventing ischemic strokes and improving patient outcomes, researchers and medical device compani...

InspireMD, a leading medical technology company, has recently announced the appointment of Pete Ligotti as their new Executive Vice President and General Manager of North America. Ligotti, a highly experienced medical t...

InspireMD Collaborates with Jacobs Institute to Pave the Way for Advancements in Stroke TreatmentMedical device company InspireMD recently announced a groundbreaking strategic agreement with the renowned Jacobs Institut...